U.S. General Merchandise and Department Stores Stock News

NasdaqCM:AEHR
NasdaqCM:AEHRSemiconductor

Aehr Test Systems Raises US$60m Equity As Valuation And Volatility Loom

Aehr Test Systems completed a $60 million follow on equity offering. The company trades on NasdaqCM under the ticker AEHR. The equity raise is a material event that could affect funding capacity and future corporate decisions. Aehr Test Systems (NasdaqCM: AEHR) now has a fresh $60 million in equity capital following its follow on offering. The stock most recently closed at $88.45, after very large gains over the past year and multi year period, including a 172.0% return over the past 30...
NasdaqGS:DPZ
NasdaqGS:DPZHospitality

Domino’s Pizza (DPZ) Same Store Sales Recovery Tests Bullish Digital Growth Narrative

Domino's Pizza (DPZ) kicked off Q1 2026 with investors watching how its recent Q4 2025 revenue of US$1.5b and basic EPS of US$5.35 stack up against last year's Q4 2024 figures of US$1.4b in revenue and EPS of US$4.89. Over the past year, the company has seen quarterly revenue move from US$1.1b in Q1 2025 to US$1.5b in Q4 2025, while basic EPS ranged from US$3.84 to US$5.35. This sets the stage for a results season where margin quality and consistency matter as much as headline growth. See our...
NasdaqGS:INMD
NasdaqGS:INMDMedical Equipment

Did Reaffirmed 2026 Revenue Guidance Just Shift InMode's (INMD) Investment Narrative?

In April 2026, InMode Ltd. reaffirmed its revenue guidance, projecting US$81.5 million to US$81.7 million for first-quarter 2026 and US$365 million to US$375 million for full-year 2026. This confirmation of management’s outlook underscores the company’s confidence in its current operating trajectory and demand visibility across its aesthetic medical device portfolio. Now we’ll examine how reaffirmed 2026 revenue guidance might influence InMode’s investment narrative built around growth,...
NasdaqGS:SVRA
NasdaqGS:SVRABiotechs

US High Growth Tech Stocks To Watch

The United States market remained flat over the last week, yet it has experienced a 30% rise over the past 12 months with earnings forecasted to grow by 16% annually. In this context of robust growth potential, identifying high-growth tech stocks involves focusing on companies that demonstrate strong innovation and adaptability to capitalize on emerging opportunities.
NYSE:AERO
NYSE:AEROAirlines

Assessing Grupo Aeroméxico (AERO) Valuation After Recent Share Price Weakness

What recent performance says about Grupo Aeroméxico. de (AERO) With no single headline event driving attention, readers are focusing on how Grupo Aeroméxico. de (AERO) has traded recently, including a month gain of 8.3% but a past 3 months decline of 28.7%. Over the past week the stock has dropped 9.3%, even as the latest session closed slightly higher at US$14.97. Year to date, shares are down 31.8%, which may prompt closer review of current valuation. See our latest analysis for Grupo...
NasdaqGS:IHRT
NasdaqGS:IHRTMedia

Discover April 2026's Undervalued Small Caps With Insider Action

The United States market has remained flat over the last week, yet it has seen a significant 30% increase over the past year with earnings anticipated to grow by 16% annually. In this environment, identifying stocks that are potentially undervalued can be crucial, especially when insider activity may indicate confidence in their future prospects.
NasdaqGS:KNSA
NasdaqGS:KNSABiotechs

High Growth Tech Stocks To Watch In The US This April 2026

In the last week, the United States market has stayed flat, yet over the past 12 months, it has risen by an impressive 30%, with earnings anticipated to grow by 16% annually in the coming years. In this dynamic environment, identifying high growth tech stocks involves focusing on companies that demonstrate strong innovation and potential for significant revenue expansion in alignment with these positive market trends.
NasdaqGS:FLNC
NasdaqGS:FLNCElectrical

3 Stocks That Might Be Undervalued By Up To 32.8%

Over the last 7 days, the United States market has remained flat, yet it has experienced a significant 30% increase over the past year with earnings forecasted to grow by 16% annually. In this environment, identifying stocks that might be undervalued can present opportunities for investors looking to capitalize on potential growth while market conditions remain favorable.
NasdaqCM:INVE
NasdaqCM:INVEElectronic

April 2026 Penny Stocks With Promising Potential

The market remained flat over the last week, but it has seen a remarkable 30% increase over the past year, with earnings expected to grow by 16% annually. For those looking to invest in smaller or newer companies, penny stocks—despite their vintage name—can still offer surprising value. With solid financial foundations, these stocks have the potential to outperform while offering greater stability.
NYSE:ASIX
NYSE:ASIXChemicals

Discovering US Hidden Gems with 3 Promising Stocks

In the last week, the United States market has stayed flat, yet over the past 12 months, it has experienced a notable rise of 30%, with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying promising stocks often involves uncovering lesser-known companies that have strong growth potential and align well with these positive market conditions.
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

US Stock Market Today: S&P 500 Futures Edge Lower As Inflation Worries Linger

The Morning Bull - US Market Morning Update Monday, Apr, 27 2026 US stock futures are slightly softer this morning, with E mini S&P 500 contracts slipping about 0.1%, as investors weigh stubborn inflation worries against a resilient tech backdrop. The US 10 year Treasury yield sits near 4.32%, which keeps borrowing costs elevated for mortgages, car loans and corporate debt. At the same time, the University of Michigan consumer sentiment index is at 49.8, the weakest on record, while...
NYSE:BHVN
NYSE:BHVNBiotechs

Biohaven Obesity Trial Milestone Puts Focus On Taldefgrobep And Valuation Gap

Biohaven has completed enrollment for its Phase 2 proof of concept trial evaluating obesity drug candidate taldefgrobep alfa. The study is assessing taldefgrobep alfa as a potential monotherapy and in combination with standard care. The company has indicated that topline results from the trial are expected later in the year. For investors tracking NYSE:BHVN, this update adds a fresh angle to a story often centered on its neurology pipeline. The stock closed at $9.88, with a 30 day return of...
NasdaqGS:KLTR
NasdaqGS:KLTRSoftware

Is Kaltura’s (KLTR) Region-Specific AI Push Quietly Reframing Its Global Enterprise Risk-Reward Profile?

Kaltura, Inc. recently expanded its AI-powered platform infrastructure to Europe, Asia-Pacific, and Canada while deepening product integrations and launching new agentic revenue engagement capabilities across major enterprise content systems. This push into compliant, region-specific AI infrastructure and unified conversational experiences could widen Kaltura’s addressable market among heavily regulated global enterprises. We’ll now examine how Kaltura’s regionally compliant AI rollout and...
NasdaqCM:ATOM
NasdaqCM:ATOMSemiconductor

A Look At Atomera (NasdaqCM:ATOM) Valuation After Expanded Synopsys GaN Modeling Collaboration

Why Atomera’s latest Synopsys collaboration matters for investors Atomera (ATOM) is drawing fresh attention after expanding its long-running collaboration with Synopsys to support gallium nitride, or GaN, device modeling for radio frequency and power semiconductor applications. The new phase uses Synopsys’ Sentaurus TCAD tools alongside Atomera’s MSTcad to build GaN calibration workflows, marketing materials, and calibrated TCAD decks, giving semiconductor customers a framework to study MST’s...
NYSE:LAW
NYSE:LAWSoftware

Assessing CS Disco (LAW) Valuation After Toby Williams Joins The Board

Board Appointment Puts Governance in Focus CS Disco (LAW) has drawn fresh attention after appointing Toby Williams, President and CEO of Paylocity, to its Board of Directors, giving investors a new governance angle to consider. Williams brings roughly 25 years of experience across AI SaaS, cloud-based software, corporate finance, product and strategy, and corporate development, as well as experience as an attorney and investment banker. This background may influence how you think about CS...